Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12Head & Neck 12Tumor-Agnostic 9Gynecologic 8Genitourinary 8Gastrointestinal 7Dermatologic 6Sarcoma 4CNS 3Other solid neoplasm 2Plasma cell 1NET 1Myeloid 1Endocrine 1

Conditions

Multiple Myeloma 292Lymphoma 45Recurrence 31Neoplasms, Plasma Cell 28Hematologic Neoplasms 25Smoldering Multiple Myeloma 20Lymphoma, Non-Hodgkin 20Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 11Myelodysplastic Syndromes 10Leukemia 10Immunoglobulin Light-chain Amyloidosis 10Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, Mantle-Cell 6Prostatic Neoplasms 5Paraproteinemias 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Breast Neoplasms 5Lymphoproliferative Disorders 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Diseases 4Colorectal Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma × Plasma cell × Clear all
NCT03915184 2023-12-19

Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

CARsgen Therapeutics Co., Ltd.

Phase 1/2 Active not recruiting
105 enrolled
Plasma cell

Carcinoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡